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Early immunological events in postoperative
epidural/intravenous analgesia after colorectal cancer
resection
Abstract
Background and purpose: Postoperative pain is a common consequence
of extensive surgery with activation of the nervous system for the im-
plementation of pain (nociceptive system), tissue injury or inflammation.
As a result of tissue injury, many different mediators are released from
damaged tissues, immunocompetent cells, sympathetic and sensory fibers
which directly or indirectly activate nociceptors. Postoperative pain leads to
suppression of the immune system, including reduced activity of NK cells,
cytotoxic T lymphocytes and macrophages.
Patients and Methods: We examined the effects of epidural and intra-
venous analgesia in patients after colorectal cancer surgery on the immune
system. We analyzed the phenotype of isolated peripheral blood mono-
nuclear cells of patients during first six postoperative days by flow cytometry
and compared them with healthy volunteers.
Results: Application of intravenous analgesia leads to statistically sig-
nificant decreasing in the percentage of cells of innate immunity in com-
parison with them after epidural analgesia. Intravenous analgesia has led to
a statistically significant reduction of subpopulation of T lymphocytes
(CD3+) and B lymphocytes (CD19+) on the 6th postoperative day com-
pared to epidural analgesia.
Conclusion: Intravenous analgesia after colorectal cancer surgery has led
to a statistically significant greater depression of innate and acquired im-
munity in comparison to epidural analgesia.
INTRODUCTION
Immune response to the cancer pain is a multimodal, because there isa whole series of interactions between factors, resulting in a complex
clinical picture changes (1–3). These changes are due to the action of
soluble factors (cytokines, chemokines), activation of hipthalamic-
-pituitary-adrenal axis (HPA activation) and sympathetic activity
(catecholamines) and parasympathetic (acetylcholine) nervous system.
Pain leads to activation of the innate and acquired cell immunity (4–6),
wherein there is a predominance of anti-inflammatory Th2 response
(IL-4, IL-10, IL-13), not pro-inflammatory Th1 immune response
(IL1-b, IL-2, IL-6, IL-8, IL-12, IFN-g and TNF-a). Consequently
there is a reduction in the number and function of T lymphocytes (helper
and cytotoxic T cells), NK cells, NKT cells, reducing the number and
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Histocompatibility Complex II (MHC-II) on the surface
of antigen-presenting cells, reduced ability to kill tumor
cells and reduced secretion of immunoglobulins (B cells).
On the similar way as cancer pain, surgery proceeding
simultaneously activates the nervous, endocrine and im-
mune system (7). Brain cortex activates the limbic system,
which leads to activation of the hypothalamic periventri-
cular nucleus and activation of HPA axis leading to se-
cretion of cortisol, which reduces the number and function
of cells of the innate and acquired immunity through the
glucocorticoid receptor (8, 9). Major surgery leads to
reflex activation of the sympathetic nervous system (SNS),
which stimulates the release of noradrenalin (NA) and
adrenaline (A) (10). Immune cells have adrenergic recep-
tors, secretion of NA and A cause immunosuppression
(11). Surgical manipulation causes ischemia of organs,
which leads to the activation of inflammatory responses;
proinflammatory cytokines TNF, interleukins (IL-1 and
IL-6) provide further activation of the HPA axis and SNS
(12, 13). Some intravenous anesthetics can reduce im-
munity and it is necessary to be careful when long conti-
nuous applications are needed (more than 24 hours), es-
pecially when used for postoperative sedation (14). Some
inhalation anesthetics may also suppress the immune
response (15). Inhibition of ROS (reactive oxygen species),
mainly supress the neutrophil function, whose task is to
eliminate harmful microorganisms (16). Activated neutro-
phils are protective alarm for the body because it trigger-
ed the initial phase of the inflammatory response (17).
PATIENTS AND METHODS
This study included 80 patients after curative surgery
(radical) bowel resection of diagnosed colorectal cancer,
committed under general balanced anesthesia. The study
also included 30 healthy blood donors as a control group.
Subjects were divided into three groups:
Group I – patients whom after elective surgical re-
section of colorectal cancer, the pain was treated with
intravenous analgesia. Group II –patients whom after
elective surgical resection of colorectal cancer, the pain
was treated using an epidural analgesia. Group III con-
trol –voluntary blood donors.
After the colorectal cancer surgery, patients be placed
on the Department of Digestive Surgery, Department of
Surgery and Intensive Care Unit, Department of Anesthe-
siology and Intensive Care, University Hospital Rijeka
where were made the continued postoperative treatment
in accordance with accepted standards. Postoperative pain
was treated to one of the above methods – intravenous or
epidural analgesia. Each patient enrolled in the study
was taken about 10 ml heparinized venous peripheral
blood before surgery, 1st and 6th day after resection of
colorectal cancer during intravenous/epidural analgesia.
Each patient prior to surgery was familiar with the visual
analog pain scale (VAS) that can record the intensity of
postoperative pain.
Phenotype of peripheral blood mononuclear cells was
determined by flow cytometry on a FACSCalibur flow
cytometer (Becton Dickinson, Muantain View, CA, USA).
Statistical analysis. data were analyzed using the Statis-
tica 7.0 per Windows. Linear regression equations were
generated using a least-squares method and analyzed for
differences of covariance.
Statistical significance was calculated by Mann Whit-
ney U test. The differences were considered significant
for p<0.05.
RESULTS
The data have shown that patients with colorectal
cancer have diminished values of immune cells. After
operation, during the recovery period in group of pati-
ents following epidural analgesia, the percentage of CD3+
cells (T lymphocytes) was augmented at 1st and 6th post-
operative day, with statistical significance p<0,05 in com-
parison with the patients underwent intravenous anal-
gesia. The interesting results was also that on the 6th
postoperative day, epidural analgesia more than intra-
venous analgesia significantly augmented B lymphocytes
(CD 19+) (Figure 1)
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Figure 1. Changes in phenotype profile of patients underwent epidural/intravenous analgesia after colorectal cancer surgery ( p<0,05). The
percentage of T helper and T cytotoxic cells was not significantlly changed during intravenous analgesia in comparisom with epidural analgesia.
DISCUSSION
Colorectal cancer is among the most common tumors
in humans. According to the frequency of cancer it is in
third place (behind lung and breast cancer) and is the
second leading cause of mortality in developed countries.
The main goal of modern analgesia is that without tak-
ing consciousness prevents physiological stress response
to surgical injury, which is reflected in significant hemo-
dynamic, metabolic and neuroimmunological changes
in the body (18). Epidural analgesia prevents stress res-
ponse inhibiting transmission of nerve impulses from
their sources using local anesthetic with or without com-
bination with opiates or opioids (19). The data em-
phasize that during the postoperative pain management,
epidural analgesia more than intravenous, prevents some
immune dysfunctions, contributing to the more efficient
postoperative recovery than the patients undergoing in-
travenous analgesia. The advantages of the epidural space
are the ability to perform segmental blocks, and anes-
thetized and make analgesia in dermatome only at the
level of surgical intervention. This concept is most com-
monly use for a combination of balanced general anes-
thesia with epidural analgesia during surgery, after which
the epidural catheter introduced during operation, per-
manently stay and we may continue intermittent epi-
dural analgesia (20). Patients with malignancies have
decreased immune response, which may very often be
additionally disrupted with intensive pain and modulate
with appropriate pain management techniques (21–23).
Although there are controversial data in the literature,
the large studies, which included more than 1,400 sub-
jects, indicated that the postoperative epidural analgesia
showed statistically significantly more effective in com-
bating pain than parenteral administration of opioids
(24). Our results showed a significantly lower immuno-
suppression caused by epidural analgesia compared with
the effect of intravenous analgesia in perioperative period
in patients after resection of colorectal cancer. We may
conclude that the selections of appropriate methods of
analgesia are invaluable for the postoperative period of
reconvalescency.
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